Hepatitis C is the commonest cause of chronic hepatitis in the US and can lead to progressive liver injury with the development of cirrhosis, liver failure and liver cancer. Liver injury may be caused by an interaction of the virus with the host immune response leading to inflammation and fibrosis in the liver. We plan to examine the mechanism of HCV induced liver injury in three distinct groups of patients: 1) those with chronic HCV infection and evidence of moderate to severe necroinflammatory disease, who are at average risk of progression to cirrhosis; 2) those with persisting viremia but normal or minimally elevated transaminases and normal or mildly inflamed liver biopsies, who are at low risk of progression to cirrhosis; and 3) patients with chronic HCV liver disease and active daily alcohol use (greater than 50 gm/day), who are at the highest risk of progression of liver disease. Specifically, we propose to evaluate the role of intrahepatic viral load on immune response and liver injury by measuring liver derived CTL response and cytokine production and correlating the immune response to the degree of liver injury. The response in the liver will be compared with that seen in the periphery to determine whether there is compartmentalization of immune responses and whether peripheral immune response can correlate with the injury and immune response seen in the liver. The role of anti-viral therapy and alcohol on these responses will also be studied. These studies may lead to insights on the mechanism of liver injury and help define those patients who are most likely to have progressive liver injury.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
1R01AA012671-01
Application #
2907049
Study Section
Special Emphasis Panel (ZDK1-GRB-5 (M1))
Project Start
1999-09-01
Project End
2002-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Polgreen, P M; Fultz, S L; Justice, A C et al. (2004) Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people. HIV Med 5:144-50
George, Sarah L; Xiang, Jinhua; Stapleton, Jack T (2003) Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology 316:191-201
Ullrich, Philip M; Lutgendorf, Susan K; Stapleton, Jack T (2003) Concealment of homosexual identity, social support and CD4 cell count among HIV-seropositive gay men. J Psychosom Res 54:205-12
Polgreen, Philip M; Putz, Darcy; Stapleton, Jack T (2003) Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus. Clin Infect Dis 37:e53-6
George, Sarah L; Gebhardt, Jenny; Klinzman, Donna et al. (2002) Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests. J Acquir Immune Defic Syndr 31:154-62
Xiang, Jinhua; Wunschmann, Sabina; George, Sarah L et al. (2002) Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays. J Med Virol 68:537-43
Xiang, J; Wunschmann, S; Diekema, D J et al. (2001) Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345:707-14
Wunschmann, S; Stapleton, J T (2000) Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia. J Clin Microbiol 38:3055-60
Xiang, J; Wunschmann, S; Schmidt, W et al. (2000) Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 74:9125-33
Wunschmann, S; Medh, J D; Klinzmann, D et al. (2000) Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 74:10055-62